S Ali Husain1, Kristen L King2, Joel T Adler3, Sumit Mohan4, Rimma Perotte5. 1. Department of Medicine, Division of Nephrology, Columbia University, New York, New York; Columbia University Renal Epidemiology Group, New York, New York. Electronic address: SAH2134@cumc.columbia.edu. 2. Department of Medicine, Division of Nephrology, Columbia University, New York, New York; Columbia University Renal Epidemiology Group, New York, New York. 3. Department of Surgery, Division of Transplant Surgery, Brigham and Women's Hospital, Boston, Massachusetts; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts. 4. Department of Medicine, Division of Nephrology, Columbia University, New York, New York; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. 5. Department of Biomedical Informatics, Columbia University, New York, New York; Columbia University Renal Epidemiology Group, New York, New York; Department of Emergency Medicine, Hackensack University Medical Center, Hackensack, New Jersey.
Abstract
RATIONALE & OBJECTIVE: The shortage of deceased donor kidneys identified for potential transplantation in the United States is exacerbated by a high proportion of deceased donor kidneys being discarded after procurement. We estimated the impact of a policy proposal aiming to increase organ utilization by extending eligibility for waiting time reinstatement for recipients experiencing early allograft failure after transplantation. STUDY DESIGN: Decision analysis informed by clinical registry data. SETTING & POPULATION: We used Organ Procurement and Transplantation Network data to identify 76,044 deceased-donor kidneys procured in the United States from 2013 to 2017, 80% of which were transplanted and 20% discarded. INTERVENTION: Extend waiting time reinstatement for recipients experiencing allograft failure from the current 90 days to 1 year after transplantation. OUTCOME: Net impact to the waitlist, defined as the estimated number of additional transplants minus estimated increase in waiting list reinstatements. MODEL, PERSPECTIVE, & TIMEFRAME: We estimated (1) the number of additional deceased donor kidneys that would be transplanted if there was a 5%-25% relative reduction in discards, and (2) the number of recipients who would regain waiting time under a 6-, 12-, 18-, and 24-month reinstatement policy. RESULTS: Reinstating a waiting time for recipients experiencing allograft failure up to 1 year after transplantation yielded more additional transplants than growth in additions to the waiting list for all model assumptions except the combination of a very low relative reduction in discards (5%) and a very high failure rate of transplanted kidneys that would previously have been discarded (≥5 times the rate of currently transplanted kidneys). LIMITATIONS: Lack of empirical evidence supporting the proposed impact of such a policy change. CONCLUSIONS: A policy change reinstating waiting time for deceased donor kidneys recipients with allograft failure up to 1 year after transplantation should explored as a decision science-based intervention to improve organ utilization.
RATIONALE & OBJECTIVE: The shortage of deceased donor kidneys identified for potential transplantation in the United States is exacerbated by a high proportion of deceased donor kidneys being discarded after procurement. We estimated the impact of a policy proposal aiming to increase organ utilization by extending eligibility for waiting time reinstatement for recipients experiencing early allograft failure after transplantation. STUDY DESIGN: Decision analysis informed by clinical registry data. SETTING & POPULATION: We used Organ Procurement and Transplantation Network data to identify 76,044 deceased-donor kidneys procured in the United States from 2013 to 2017, 80% of which were transplanted and 20% discarded. INTERVENTION: Extend waiting time reinstatement for recipients experiencing allograft failure from the current 90 days to 1 year after transplantation. OUTCOME: Net impact to the waitlist, defined as the estimated number of additional transplants minus estimated increase in waiting list reinstatements. MODEL, PERSPECTIVE, & TIMEFRAME: We estimated (1) the number of additional deceased donor kidneys that would be transplanted if there was a 5%-25% relative reduction in discards, and (2) the number of recipients who would regain waiting time under a 6-, 12-, 18-, and 24-month reinstatement policy. RESULTS: Reinstating a waiting time for recipients experiencing allograft failure up to 1 year after transplantation yielded more additional transplants than growth in additions to the waiting list for all model assumptions except the combination of a very low relative reduction in discards (5%) and a very high failure rate of transplanted kidneys that would previously have been discarded (≥5 times the rate of currently transplanted kidneys). LIMITATIONS: Lack of empirical evidence supporting the proposed impact of such a policy change. CONCLUSIONS: A policy change reinstating waiting time for deceased donor kidneys recipients with allograft failure up to 1 year after transplantation should explored as a decision science-based intervention to improve organ utilization.
Authors: Kristen L King; S Ali Husain; Jesse D Schold; Rachel E Patzer; Peter P Reese; Zhezhen Jin; Lloyd E Ratner; David J Cohen; Stephen O Pastan; Sumit Mohan Journal: J Am Soc Nephrol Date: 2020-10-09 Impact factor: 10.121
Authors: Robert M Merion; Valarie B Ashby; Robert A Wolfe; Dale A Distant; Tempie E Hulbert-Shearon; Robert A Metzger; Akinlolu O Ojo; Friedrich K Port Journal: JAMA Date: 2005-12-07 Impact factor: 56.272
Authors: Jesse D Schold; Laura D Buccini; David A Goldfarb; Stuart M Flechner; Emilio D Poggio; Ashwini R Sehgal Journal: Clin J Am Soc Nephrol Date: 2014-09-18 Impact factor: 8.237
Authors: Daniel W Kim; Demetra Tsapepas; Kristen L King; S Ali Husain; Frank A Corvino; Allison Dillon; Weiying Wang; Tracy J Mayne; Sumit Mohan Journal: Clin Transplant Date: 2020-08-11 Impact factor: 2.863
Authors: Sumit Mohan; Karl Foley; Mariana C Chiles; Geoffrey K Dube; Rachel E Patzer; Stephen O Pastan; R John Crew; David J Cohen; Lloyd E Ratner Journal: Kidney Int Date: 2016-05-12 Impact factor: 10.612
Authors: Syed A Husain; Kristen L King; David C Cron; Nikole A Neidlinger; Han Ng; Sumit Mohan; Joel T Adler Journal: Am J Transplant Date: 2022-03-07 Impact factor: 9.369